Thorne Healthtech, Inc. (THRN): Price and Financial Metrics


Thorne Healthtech, Inc. (THRN): $5.76

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add THRN to Watchlist
Sign Up

Industry: Food Makers


Ranked

of

in industry

THRN Stock Price Chart Interactive Chart >

Price chart for THRN

THRN Price/Volume Stats

Current price $5.76 52-week high $10.13
Prev. close $5.76 52-week low $4.17
Day low $5.55 Volume 75,300
Day high $5.82 Avg. volume 93,979
50-day MA $6.33 Dividend yield N/A
200-day MA $0.00 Market Cap 303.72M

Thorne Healthtech, Inc. (THRN) Company Bio


Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.


THRN Latest News Stream


Event/Time News Detail
Loading, please wait...

THRN Latest Social Stream


Loading social stream, please wait...

View Full THRN Social Stream

Latest THRN News From Around the Web

Below are the latest news stories about Thorne Healthtech Inc that investors may wish to consider to help them evaluate THRN as an investment opportunity.

Thorne HealthTech Announces Fourth Quarter and Full-Year 2021 Earnings Conference Call

Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will host a conference call on Tuesday, March 15, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2021 financial results. A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com. A replay will be available on the same website after

Yahoo | February 25, 2022

UFC® AND THORNE ANNOUNCE MULTI-YEAR EXTENSION OF PARTNERSHIP

UFC®, the world's premier mixed martial arts organization, and Thorne Health Tech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, today announced a multi-year extension of their global marketing partnership. Thorne remains the Official Sports Performance Nutrition Partner of UFC and an official partner of the UFC Performance Institute®, the world's first Mixed Martial Arts (MMA) multi-discipl

Yahoo | February 24, 2022

Tetra Bio-Pharma Inc (TBPMF) Signs License Agreement with Thorne for a Prebiotic Dietary Supplement

Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement Tetra Bio-Pharma Inc (Tetra or the Company) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, today announced it has signed a Licensing Agreement with Thorne Health Tech, Inc. (Thorne HealthTech or Thorne) (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, for the commercialization of its patent protected prebiotic dietary supplement in the U.S. market. The Agreement will include royalty on sales and milestone payments. The prebiotics market size in the United States is expected to exceed USD 9.5bn by 2027 with a strong CAGR of 9.6% in 2021. Thorne has an established reputation as a world ...

Marijuana Stocks | February 22, 2022

Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement

Tetra Bio-Pharma Inc ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, today announced it has signed a Licensing Agreement with Thorne Health Tech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, for the commercialization of its patent protected prebiotic dietary supplement in the U.S. market. The Agreement will incl

Yahoo | February 22, 2022

Thorne HealthTech Joins Hand With Mitsui To Form Thorne Asia JV

Thorne HealthTech Inc (NASDAQ: THRN) has agreed to form a joint venture with Mitsui & Co Ltd (OTC: MITSY) called Thorne HealthTech Asia Pte. Ltd. (Thorne Asia). The JV is expected to expand access to Thorne's solutions and personalized approaches to address health and wellbeing across Asia. Thorne Asia JV will promote and provide Thorne's diagnostics, analytics, and supplement offerings online and through medical and retail providers and use Mitsui's retail expertise and relationships in the reg

Yahoo | January 13, 2022

Read More 'THRN' Stories Here

THRN Price Returns

1-mo -6.65%
3-mo 22.55%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD -7.25%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4792 seconds.